SCD and Hepatic steatosis: In fact mice with a natural or a targeted deletion of the SCD1 gene, have shown to be protected against hypertriglyceridemia [7], hepatic steatosis [8]–[10], obesity [3], [5], [8], [11], [12] and insulin resistance [11], [13], [14].